One concern with in vivo CAR-Ts is the potential insertional mutagenesis of the lentiviral DNA payload, causing secondary ...

AstraZeneca plans to acquire Belgian in vivo cell therapy biotech EsoBiotec and has signed a pair of licensing deals with drug delivery firm Alteogen. Medical affairs is evolving. Once primarily ...

Chimeric antigen receptor (CAR) T-cell therapies have drastically changed treatment paradigms in relapsed and refractory (R/R) haematological malignancies since the approval of the first CAR-T ...

A phase 1b showed promising results in lowering LDL in patients with heterozygous familial hypercholesterolemia and/or ...

AstraZeneca and Honeywell are developing MDIs that will use a new propellant called HFO-1234ze, which, according to the company, has 99.9% less Global Warming Potential (GWP) than existing ...

Chipmaker Intel is selling a 51 per cent stake in its Altera programmable chip unit to buyout firm Silver Lake, for $4.46 billion, in a deal that values the struggling business at $8.75 billion ...

Reliance Industries Ltd (RIL) has acquired an additional 10 per cent equity stake in Nauyaan Shipyard Pvt Ltd (NSPL), a subsidiary of Wellspun Corporation, in a deal valued at Rs51.72 crore.

Austin, April 11, 2025 (GLOBE NEWSWIRE) -- Global Biotechnology Market Size & Growth Analysis: According to a recent report by SNS Insider, the global Biotechnology Market was valued at USD 2100 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...